Commercial Physical & Biological Research Industry - SEC Form 4 Insider Trading Screener

Services Sector - Engineering, Accounting, Research, Management Services - Commercial Physical & Biological Research
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2018-11-15
EXELExelixis, Inc.Morrissey MichaelPres, CEOS - Sale+OE$17.22-25,000301,352-8%-$430,500
D
2018-11-12
EXASExact Sciences CorpZanotti Katherine SDirS - Sale+OE$69.00-7,667102,102-7%-$529,023
D
2018-11-12
EXASExact Sciences CorpConroy Kevin TPres, CEOS - Sale+OE$69.00-163,514976,780-14%-$11,282,466
2018-11-12
CRLCharles River Laboratories International IncSmith David RossCorporate EVP, CFOS - Sale$134.49-1,86610,575-15%-$250,961
2018-11-12
NRCNational Research CorpK/i/e/trust Under Agreement 3/9/0910%S - Sale$40.00-2,1735,379,8250%-$86,920
2018-11-07
EXELExelixis, Inc.Haley Patrick J.SVP, CommercialS - Sale$17.32-20,000138,739-13%-$346,400
2018-11-08
INCYIncyte CorpBienaime Jean JacquesDirP - Purchase$68.77+1,0006,668+18%+$68,765
D
2018-11-07
CRLCharles River Laboratories International IncJohst David PCorporate EVPS - Sale+OE$136.00-23,356196,493-11%-$3,176,416
M
2018-11-05
EXASExact Sciences CorpLidgard Graham PeterChief Science OfficerS - Sale$75.01-38,31141,040-48%-$2,873,633
D
2018-11-01
EXELExelixis, Inc.Schwab GiselaPres, Prod Dev, Med Aff, CMOS - Sale+OE$14.16-12,000342,793-3%-$169,920
2018-11-01
EXELExelixis, Inc.Scangos George ADirS - Sale$14.66-25,0001,535,576-2%-$366,400
D
2018-11-02
EXELExelixis, Inc.Morrissey MichaelPres, CEOS - Sale+OE$17.57-37,499318,705-11%-$658,964
M
2018-10-31
EXASExact Sciences CorpLidgard Graham PeterChief Science OfficerS - Sale$71.73-79,67379,351-50%-$5,714,841
2018-10-15
XONIntrexon CorpLiffman Joel DSVP, FinanceS - Sale$14.59-79,00079,500-50%-$1,152,808
2018-10-08
EXASExact Sciences CorpLidgard Graham PeterChief Science OfficerS - Sale$69.36-58,000159,024-27%-$4,022,933
D
2018-10-03
INCYIncyte CorpTrower PaulPrincipal Accounting OfficerS - Sale+OE$70.00-10,00014,172-41%-$700,000
D
2018-10-03
INCYIncyte CorpSwain Paula JEVP, HRS - Sale+OE$70.00-10,00032,324-24%-$700,000
2018-10-03
INCYIncyte CorpFlannelly Barry PEVP, GM USS - Sale$70.00-1,00012,427-7%-$70,000
2018-10-01
EXELExelixis, Inc.Scangos George ADirS - Sale$17.86-25,0001,560,576-2%-$446,500
D
2018-10-01
EXELExelixis, Inc.Morrissey MichaelPres, CEOS - Sale+OE$17.82-12,501318,705-4%-$222,768
D
2018-10-01
EXELExelixis, Inc.Schwab GiselaPres, Prod Dev, Med Aff, CMOS - Sale+OE$17.77-12,000342,793-3%-$213,240
D
2018-10-01
EXASExact Sciences CorpCoward D ScottChief Administrative OfficerS - Sale+OE$79.51-2,19079,546-3%-$174,118
M
2018-09-25
MEDPMedpace Holdings, Inc.Troendle August J.Pres, CEO, 10%S - Sale$58.58-132,3049,257,361-1%-$7,750,266
M
2018-09-25
MEDPMedpace Holdings, Inc.Medpace Investors, LLC10%S - Sale$58.58-132,3048,895,510-1%-$7,750,266
2018-09-24
EXELExelixis, Inc.Scangos George ADirS - Sale$16.85-25,0001,585,576-2%-$421,250
DM
2018-09-18
NRCNational Research CorpKaras Kevin RSVP Finance, CFO, Treas, SecyS - Sale+OE$39.53-4,80015,316-24%-$189,738
2018-09-21
MEDPMedpace Holdings, Inc.Troendle August J.Pres, CEO, 10%S - Sale$58.47-2,7139,389,6650%-$158,629
2018-09-21
MEDPMedpace Holdings, Inc.Medpace Investors, LLC10%S - Sale$58.47-2,7139,027,8140%-$158,629
M
2018-09-19
MEDPMedpace Holdings, Inc.Medpace Investors, LLC10%S - Sale$59.31-114,9839,030,527-1%-$6,819,261
M
2018-09-19
MEDPMedpace Holdings, Inc.Troendle August J.Pres, CEO, 10%S - Sale$59.31-114,9839,392,378-1%-$6,819,138
D
2018-09-21
NRCINational Research CorpBerwick Donald MDirS - Sale+OE$38.20-2290-100%-$8,748
DM
2018-09-18
NRCNational Research CorpKaras Kevin RSVP Finance, CFO, Treas, SecyS - Sale+OE$39.53-4,80015,316-24%-$189,738
2018-09-18
NRCNational Research CorpK/i/e/trust Under Agreement 3/9/0910%S - Sale$40.00-1,4515,381,9980%-$58,040
DM
2018-09-06
NRCINational Research CorpBerwick Donald MDirS - Sale+OE$38.79-17,137229-99%-$664,717
2018-09-17
SNMXSenomyx IncSenvest Management, LLC10%S - Sale$1.48-2,689,5043,663,101-42%-$3,967,825
2018-09-14
BASIBioanalytical Systems IncKissinger Peter10%P - Purchase$1.74+10,0001,881,677+1%+$17,382
2018-09-14
BASIBioanalytical Systems IncNeff R MatthewDirP - Purchase$1.66+2,50015,000+20%+$4,150
2018-09-14
PIRSPieris Pharmaceuticals, Inc.Kiritsy Christopher PDirP - Purchase$5.11+5,00010,000+100%+$25,525
2018-09-13
IQVIqvia Holdings Inc.Danhakl John GDirS - Sale$126.47-413,233134,440-75%-$52,263,088
DM
2018-09-12
SRNESorrento Therapeutics, Inc.Abg Management Ltd10%S - Sale+OE$5.02-297,5686,791,335-4%-$1,492,723
M
2018-09-11
IQVIqvia Holdings Inc.Danhakl John GDirS - Sale$124.83-370,470576,984-39%-$46,244,717
2018-09-11
BASIBioanalytical Systems IncDowning Philip ASVP, Preclinical Srvcs.P - Purchase$1.67+5,00020,765+32%+$8,350
A
2018-09-07
IQVIqvia Holdings Inc.Danhakl John GDirS - Sale$126.63-221,9003,154,267-7%-$28,099,197
D
2018-09-07
IQVIqvia Holdings Inc.Knightly Kevin CSee RemarksS - Sale+OE$126.46-9,21619,323-32%-$1,165,455
2018-09-07
IQVIqvia Holdings Inc.Danhakl John GDirS - Sale$126.63-221,9003,154,267-7%-$28,099,197
D
2018-09-04
EXELExelixis, Inc.Schwab GiselaPres Prod Dev, Med Aff, CMOS - Sale+OE$18.53-22,500342,793-6%-$416,925
DM
2018-09-04
NRCINational Research CorpBerwick Donald MDirS - Sale+OE$39.03-5,26317,366-23%-$205,400
D
2018-09-04
INCYIncyte CorpSwain Paula JEVP, HRS - Sale+OE$73.21-10,00032,324-24%-$732,100
2018-09-04
CRLCharles River Laboratories International IncKochevar Deborah TurnerDirS - Sale$123.66-4,0666,424-39%-$502,799
2018-08-30
HPPIHedgepath Pharmaceuticals, Inc.Hasara Garrison J.CFO, TreasurerS - Sale$0.27-100,0003,959,044-2%-$27,000
D
2018-08-28
NRCINational Research CorpBerwick Donald MDirS - Sale+OE$39.42-60022,629-3%-$23,650
2018-08-28
EXASExact Sciences CorpWyzga Michael SDirS - Sale$74.85-2,4689,112-21%-$184,730
M
2018-08-24
NRCNational Research CorpK/i/e/trust Under Agreement 3/9/0910%S - Sale$40.00-14,4855,383,4490%-$579,400
2018-08-27
MEDPMedpace Holdings, Inc.Medpace Limited Partnership10%S - Sale$54.75-5,224,9970-100%-$286,068,586
M
2018-08-22
NRCNational Research CorpK/i/e/trust Under Agreement 3/9/0910%S - Sale$38.14-161,7494,397,934-4%-$6,168,842
D
2018-08-20
EXELExelixis, Inc.Morrissey MichaelPres, CEOS - Sale+OE$17.82-90,000318,705-22%-$1,604,216
D
2018-08-21
INCYIncyte CorpSwain Paula JEVP, HRS - Sale+OE$70.00-10,00032,324-24%-$700,000
M
2018-08-17
NRCNational Research CorpK/i/e/trust Under Agreement 3/9/0910%S - Sale$38.03-38,4805,559,683-1%-$1,463,503
D
2018-08-15
EXELExelixis, Inc.Marchesi Vincent TDirS - Sale+OE$19.50-40,000133,850-23%-$780,000
M
2018-08-13
NRCNational Research CorpK/i/e/trust Under Agreement 3/9/0910%S - Sale$38.05-41,3935,598,163-1%-$1,574,900
D
2018-08-13
CRLCharles River Laboratories International IncSmith David RossCorporate EVP, CFOS - Sale+OE$120.06-1,24912,441-9%-$149,948
M
2018-08-09
NRCNational Research CorpK/i/e/trust Under Agreement 3/9/0910%S - Sale$38.00-4,3645,639,5560%-$165,832
2018-08-09
PRAHPra Health Sciences, Inc.Kkr Pra Investors L.P.10%S - Sale$101.01-6,500,0006,695,984-49%-$656,565,000
2018-08-09
SYNHSyneos Health, Inc.Thomas H. Lee Advisors, LLC10%S - Sale$49.73-6,000,00019,252,226-24%-$298,380,000
2018-08-09
SYNHSyneos Health, Inc.Thomas H. Lee Advisors, LLC10%S - Sale$49.73-6,000,00019,252,226-24%-$298,380,000
2018-08-10
MEDPMedpace Holdings, Inc.Medpace Limited Partnership10%S - Sale$54.35-5,175,0005,224,997-50%-$281,261,250
DM
2018-08-07
EXELExelixis, Inc.Morrissey MichaelPres, CEOS - Sale+OE$21.04-234,267318,705-42%-$4,928,523
2018-08-07
MEDPMedpace Holdings, Inc.Troendle August J.Pres, CEO, 10%S - Sale$57.06-138,1059,507,361-1%-$7,880,271
2018-08-06
EXELExelixis, Inc.Haley Patrick J.SVP, CommercialS - Sale$20.92-2,361158,735-1%-$49,392
M
2018-08-06
NRCNational Research CorpK/i/e/trust Under Agreement 3/9/0910%S - Sale$38.00-56,3345,643,920-1%-$2,140,734
A
2018-08-02
NRCNational Research CorpK/i/e/trust Under Agreement 3/9/0910%S - Sale$38.00-7,3615,700,2540%-$279,718
M
2018-08-02
MEDPMedpace Holdings, Inc.Troendle August J.Pres, CEO, 10%S - Sale$59.26-731,4609,645,466-7%-$43,344,976
2018-08-02
MEDPMedpace Holdings, Inc.Geiger Jesse JCFO, COO, Lab OperationsS - Sale$60.15-7,4070-100%-$445,531
2018-08-02
IQVIqvia Holdings Inc.Parks RobertSVP, ControllerS - Sale$124.34-8711,195-42%-$108,304
D
2018-08-01
EXELExelixis, Inc.Schwab GiselaPres Prod Dev, Med Aff, CMOS - Sale+OE$20.56-22,500292,793-7%-$462,600
M
2018-07-31
NRCNational Research CorpK/i/e/trust Under Agreement 3/9/0910%S - Sale$38.00-12,4905,703,5200%-$474,644
2018-07-30
EXASExact Sciences CorpZanotti Katherine SDirS - Sale$58.86-2,847106,197-3%-$167,574
2018-07-30
EXASExact Sciences CorpFallon John A.DirS - Sale$58.86-2,37333,767-7%-$139,675
2018-07-30
EXASExact Sciences CorpDoyle James EdwardDirS - Sale$58.86-1,31837,093-3%-$77,577
2018-07-30
EXASExact Sciences CorpCarey Thomas D.DirS - Sale$58.86-3,42748,983-7%-$201,713
D
2018-07-30
EXASExact Sciences CorpElliott Jeffrey ThomasCFOS - Sale+OE$57.78-8,98433,237-21%-$519,096
D
2018-07-26
IQVIqvia Holdings Inc.Bousbib AriSee RemarksS - Sale+OE$122.09-368,6401,331,519-22%-$45,007,258
D
2018-07-26
IQVIqvia Holdings Inc.Rittenmeyer Ronald ADirS - Sale+OE$122.41-7,68059,307-11%-$940,109
D
2018-07-24
CRLCharles River Laboratories International IncMolho DavidePres, COOS - Sale+OE$125.00-18,77357,903-24%-$2,346,625
2018-07-23
CRLCharles River Laboratories International IncMolho DavidePres, COOS - Sale$125.00-11,60062,827-16%-$1,450,000
D
2018-07-18
XONIntrexon CorpSabzevari HelenPres, Precigen, Inc.S - Sale+OE$14.54-8,40216,598-34%-$122,165
D
2018-07-17
CRLCharles River Laboratories International IncMolho DavidePres, COOS - Sale+OE$120.00-11,12674,427-13%-$1,335,120
D
2018-07-16
LUNALuna Innovations IncCarilion Clinic10%S - Sale+OE$3.40-39,4972,164,330-2%-$134,290
2018-07-17
CRLCharles River Laboratories International IncGirshick BirgitCorporate EVPS - Sale$119.90-3,97818,999-17%-$476,962
D
2018-07-16
EXELExelixis, Inc.Morrissey MichaelPres, CEOS - Sale+OE$21.13-90,000318,705-22%-$1,901,700
AM
2018-07-06
NRCNational Research CorpK/i/e/trust Under Agreement 3/9/0910%S - Sale$38.00-6,9945,716,0100%-$265,772
M
2018-07-06
NRCNational Research CorpK/i/e/trust Under Agreement 3/9/0910%S - Sale$38.00-6,9945,716,0100%-$265,772
2018-07-09
LUNALuna Innovations IncCarilion Clinic10%S - Sale$3.40-8,9552,044,7300%-$30,447
D
2018-07-09
INCYIncyte CorpSwain Paula JEVP, HRS - Sale+OE$71.11-10,00032,963-23%-$711,100
2018-07-09
INCYIncyte CorpIyengar Vijay KEVP GPS, BD, LicensingS - Sale$71.34-6068,103-7%-$43,232
M
2018-07-06
NRCNational Research CorpK/i/e/trust Under Agreement 3/9/0910%S - Sale$38.00-6,9945,716,0100%-$265,772
2018-07-03
XONIntrexon CorpKirk Randal JCEO, 10%P - Purchase$13.37+7,479,43166,789,237+13%+$99,999,992
M
2018-07-03
NRCNational Research CorpK/i/e/trust Under Agreement 3/9/0910%S - Sale$38.00-7,7195,723,0040%-$293,347
2018-07-02
CRLCharles River Laboratories International IncFoster James CCOB, CEOS - Sale$111.55-2,775322,178-1%-$309,540
2018-07-02
CRLCharles River Laboratories International IncFoster James CCOB, CEOS - Sale$111.34-5,348274,451-2%-$595,462
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top